StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

Cyclopentolat

Cyclopentolate

HCID 2905
NotizenReaktionen
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
512-15-2
Standard-SMILES
CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1
InChIKey
SKYSRIRYMSLOIN-UHFFFAOYSA-N
Summenformel
C17H25NO3
Durchschnittliche Molmasse
291,4 g/mol
Monoisotopische Masse
291,18344366

Überblick

Cyclopentolate is a carboxylic ester resulting from the formal condensation of (1-hydroxycyclopentyl)(phenyl)acetic acid with N,N-dimethylethanolamine. A tertiary amine antimuscarinic with actions similar to atropine, it is used as its hydrochloride salt to produce mydriasis (excessive dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) for opthalmic diagnostic procedures. It acts more quickly than atropine and has a shorter duration of action. It has a role as a diagnostic agent, a muscarinic antagonist, a parasympatholytic and a mydriatic agent. It is a tertiary alcohol, a carboxylic ester and a tertiary amino compound. It is functionally related to a N,N-dimethylethanolamine and a (1-hydroxycyclopentyl)phenylacetic acid.

Namen und Bezeichner

Bevorzugter Name
Cyclopentolate
IUPAC
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate
Lokaler Name
Cyclopentolat
Englischer Name
Cyclopentolate
Summenformel
C17H25NO3
Molmasse
291.39

Namen und Synonyme

cyclopentolate512-15-2Ciclopentolato2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetateCyclopentolatumBell Pentolate(+-)-cyclopentolateI76F4SHP7J2-(Dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate1-hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl esteralpha-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl esterbeta-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate
Weitere Namen anzeigen
CypleginMydrilateyclopentolateCyclopentylateCyclopentoiateDL-Cyclopentolateβ-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate2-(Dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate
CHEBI:4024beta-(Dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetateDTXSID30485282-phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl esterBenzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl esterRefChem:56554DTXCID4027995S01FA04

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,7
Polarare Oberfläche (TPSA)
49,8 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
7
Schwere Atome
21
Formalladung
0
Komplexität
331

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals
LogP2.4
Solubility1.50e+00 g/L
Human Drugs · 3 Einträge

Breast Feeding; Lactation; Mydriatics; Muscarinic Antagonists; Parasympatholytics

Pharmaceuticals

Diagnostic agents > Ophthalmic medicines

Melting Point · 2 Einträge

134-136

139 °C (hydrochloride salt)

Physical DescriptionSolid
Collision Cross Section166.35 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Siedepunkt
409.7 · 409.7±20.0 °C(Predicted)
Dichte
1.136 · 1.136±0.06 g/cm3(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationREACH registered substance: Cyclopentolate (EC: 208-136-4)
Other Safety InformationIMAP assessments - Benzeneacetic acid, .alpha.-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

Alarmwort
Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

S01FA04

S - Sensory organs

QS - Sensory organs

Pharmacodynamics · 1 Eintrag

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Mechanism of ActionBy blocking muscarinic receptors, cyclopentolate produces dilatation of the pupil (mydriasis) and prevents the eye from accommodating for near vision (cycloplegia).
MeSH Pharmacological Classification · 3 Einträge

Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

Absorption, Distribution and ExcretionAbsorbed following ophthalmic administration.
Cellular LocationsCytoplasm

Verwendung und Herstellung

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
512-15-2
PubChem CID
2905
DTXSID
DTXSID3048528
ChEMBL
CHEMBL1201338
ChEBI
CHEBI:4024
UNII
I76F4SHP7J
EC Number
208-136-4
Nikkaji
J264.904G、J264.905E、J6.274J
pka
7.93 · pKa 7.93(H2O ) (Uncertain)
UsesUse (kg; approx.) in Germany (2009): >10
Use ClassificationPharmaceuticals

Anwendungen

VerwendenCyclopentolate is an effective mydriatic and cycloplegic that begins to act very quickly and has a relatively short duration. It is used also in ophthalmoscopy for causing pre-operational mydriasis.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Magnesium2-ChlorethyldimethylaminSodium phenylacetateCyclopentanon2-Brompropan

Anbieter16 Anbieter

杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
普善实业(陕西)有限公司029-81310890 18165209495 · [email protected]
Suzhou ARTK Medchem Co., Ltd.+86-18168183658 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
Aladdin Scientific[email protected]
Syntechem Co.,Ltd[email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
常州科化生物科技有限公司0519-68985668 13685222090 · [email protected]
Pure Chemistry Scientific Inc.001-857-928-2050 or 1-888-588-9418 · [email protected]
上海贤鼎生物科技有限公司4009209199 · [email protected]
上海伯韵医药科技有限公司13817873692 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
江苏艾康生物医药研发有限公司025-66113011 19370895928 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
陕西缔都医药有限责任公司81148925 17391631969 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A carboxylic ester resulting from the formal condensation of (1-hydroxycyclopentyl)(phenyl)acetic acid with N,N-dimethylethanolamine. A tertiary amine antimuscarinic with actions similar to atropine, it is used as its ydrochloride salt to produce mydriasis (excessive dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) for opthalmic diagnostic procedures. It acts more quickly than atropine and has a shorter duration of action.